1. Title of Derivative Security (Instr. 4) |
2. Date Exercisable and Expiration Date (Month/Day/Year) |
3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) |
4. Conversion or Exercise Price of Derivative Security |
5. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 5) |
6. Nature of Indirect Beneficial Ownership (Instr. 5) |
Date Exercisable |
Expiration Date |
Title |
Amount or Number of Shares |
Stock Option (right to buy)
|
Â
(1)
|
07/06/2025 |
Common Stock
|
35,000
|
$
1.59
|
D
|
Â
|
Stock Option (right to buy)
|
Â
(2)
|
01/06/2026 |
Common Stock
|
30,000
|
$
1.08
|
D
|
Â
|
Stock Option (right to buy)
|
Â
(3)
|
05/25/2026 |
Common Stock
|
100,000
|
$
0.92
|
D
|
Â
|
Stock Option (right to buy)
|
Â
(4)
|
02/07/2027 |
Common Stock
|
100,000
|
$
0.6
|
D
|
Â
|
Stock Option (right to buy)
|
Â
(5)
|
02/07/2027 |
Common Stock
|
33,333
|
$
0.6
|
D
|
Â
|
* |
If the form is filed by more than one reporting person, see Instruction 5(b)(v). |
** |
Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). |
(1) |
This option vested as to 25% of the shares underlying such option on July 7, 2016 and the remaining 75% vests in equal monthly installments through July 7, 2019. |
(2) |
This option vests in equal monthly installments beginning February 7, 2016 through January 7, 2020. |
(3) |
This option vests in equal monthly installments beginning June 26, 2016 through May 26, 2020. |
(4) |
This option vests in equal monthly installments beginning March 8, 2017 through February 8, 2021. |
(5) |
On February 8, 2017, the reporting person was granted an option to purchase 50,000 shares of common stock. Subject to the achievement of three performance milestones relating to the company's clinical trials and regulatory filings, one third of the option vests on February 8, 2018, and two thirds of the option vests on February 8, 2019. On June 21, 2017, the first two performance milestones were met. As a result, one third of the option will vest on February 8, 2018, and one third of the option will vest on February 8, 2019, in each case subject to the reporting person's continued service to the company. |